These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

266 related items for PubMed ID: 12000494

  • 1. Bee-venom allergy in children: long-term predictive value of standardized challenge tests.
    Schuetze GE, Forster J, Hauk PJ, Friedl K, Kuehr J.
    Pediatr Allergy Immunol; 2002 Feb; 13(1):18-23. PubMed ID: 12000494
    [Abstract] [Full Text] [Related]

  • 2. Venom immunotherapy for preventing allergic reactions to insect stings.
    Boyle RJ, Elremeli M, Hockenhull J, Cherry MG, Bulsara MK, Daniels M, Oude Elberink JN.
    Cochrane Database Syst Rev; 2012 Oct 17; 10(10):CD008838. PubMed ID: 23076950
    [Abstract] [Full Text] [Related]

  • 3. Patients still reacting to a sting challenge while receiving conventional Hymenoptera venom immunotherapy are protected by increased venom doses.
    Ruëff F, Wenderoth A, Przybilla B.
    J Allergy Clin Immunol; 2001 Dec 17; 108(6):1027-32. PubMed ID: 11742283
    [Abstract] [Full Text] [Related]

  • 4. Three days rush venom immunotherapy in bee allergy: safe, inexpensive and instantaneously effective.
    Goldberg A, Yogev A, Confino-Cohen R.
    Int Arch Allergy Immunol; 2011 Dec 17; 156(1):90-8. PubMed ID: 21447964
    [Abstract] [Full Text] [Related]

  • 5. Long-term follow-up of re-sting reactions in children with moderate to severe venom hypersensitivity.
    Ertoy Karagol HI, Bakirtas A, Yilmaz O, Topal E, Arga M, Demirsoy MS, Turktas I.
    Eur J Pediatr; 2015 Jul 17; 174(7):891-6. PubMed ID: 25563216
    [Abstract] [Full Text] [Related]

  • 6. Exclusive Bee Venom Allergy: Risk Factors and Outcome of Immunotherapy.
    Rosman Y, Nashef F, Cohen-Engler A, Meir-Shafrir K, Lachover-Roth I, Confino-Cohen R.
    Int Arch Allergy Immunol; 2019 Jul 17; 180(2):128-134. PubMed ID: 31216540
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Long-term efficacy of venom immunotherapy.
    Hafner T, DuBuske L, Kosnik M.
    Ann Allergy Asthma Immunol; 2008 Feb 17; 100(2):162-5. PubMed ID: 18320918
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. A twenty-two-year experience with Hymenoptera venom immunotherapy in a US pediatric tertiary care center 1996-2018.
    Albuhairi S, El Khoury K, Yee C, Schneider L, Rachid R.
    Ann Allergy Asthma Immunol; 2018 Dec 17; 121(6):722-728.e1. PubMed ID: 30102964
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Long-Term Follow-Up of Children after Venom Immunotherapy: Low Adherence to Anaphylaxis Guidelines.
    Fiedler C, Miehe U, Treudler R, Kiess W, Prenzel F.
    Int Arch Allergy Immunol; 2017 Dec 17; 172(3):167-172. PubMed ID: 28380475
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.